Toll Free: 1-888-928-9744

Global HIV Diagnostics Market Analysis By Product (Antibody Tests, Viral Identification Assays, CD4 Testing, Viral Load Testing, Early Infant Diagnosis) And Segment Forecasts To 2022

Published: Dec 29, 2015 | Pages: 95 | Publisher: Grand View Research | Industry: Healthcare | Report Format: Electronic (PDF)

Global HIV Diagnostics Market is expected to reach USD 4.48 billion by 2022, growing at an estimated CAGR of 9.5% from 2015 to 2022, according to a new study by Grand View Research, Inc. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

Further key findings from the study suggest:

Antibody HIV diagnostic tests accounted for the largest share of the market in 2014. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA and RIPA.  These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.

Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2014. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature and portable to the point of care to enhance their market usability and accessibility in resource limited HIV affected regions.

It is expected that during the forecast period a number of novel point of care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products s expected to fuel the growth of this market over the forecast period.

North America was observed to account for the largest share of the market in 2014, which can be attributed to the presence of a strong healthcare R&D scenario in which the presence of government funding and ongoing corporate efforts to enhance product portfolio are anticipated to accelerate the timelines for new product development. Furthermore, the presence of favorable reimbursements policies for HIV and other infectious diseases is also a factor accounting for this region’s large share.

Asia Pacific is expected to grow at a relatively faster rate over the forecast period owing to, the presence of high levels of unmet market demand for HIV screening and testing. Moreover, collaborations among market participants from the western regions is another significant expected to boost the growth of Asia Pacific HIV diagnostics market during the forecast period.

Key players of the market include Janssen Diagnostics, Daktari Diagnostics, Cepheid, Hologic and Chembio Diagnostic Systmes Inc.
 Table of Contents

HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 – 2022) 

• Antibody Tests
 HIV-1 Screening Tests
  Home Access Dried Blood Spot
  Rapid Tests (Dot plot, Agglutination Tests)
 HIV-1 Antibody Confirmatory Tests
  Western Blot Test
  ndirect Immunofluorescent Antibody Assay (IFA)
  Line Immunoassay
  RadioImmunoPrecipitation Assay (RIPA)
 HIV-2 & Group O Diagnostic Tests
  Blood Antibody Tests
  ;Dried Blood Spot (DBS) Test
  Others and (Oral, Urine)
• Viral Identification Assays
 P24 Antigen Test
 Qualitative PCR Tests
 Viral Culture
• CD4 Testing
•  Viral Load Testing
• Early Infant Diagnostics

HIV Diagnostics Regional Outlook (Revenue, USD Million, 2012 – 2022) 

• North America
  U.S. HIV Diagnostics Market, by Product
  Canada HIV Diagnostics Market, by Product
• Europe
  Germany HIV Diagnostics Market, by Product
  UK HIV Diagnostics Market, by Product
• Asia Pacific
  Japan HIV Diagnostics Market, by Product
  China HIV Diagnostics Market, by Product
• Latin America
  Brazil HIV Diagnostics Market, by Product
 South Africa
  South Africa HIV Diagnostics Market, by Product

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot


Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ


Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected


Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain


Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Choose License Type
Single User - US $4950
Multi User - US $7950
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.